- Corporate Officers - A
- Abernathy Robert E
Insider Trading History of Abernathy Robert E
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Abernathy Robert E since 2006.
The trader's CIK number is 1222888.
At the time of the last reporting, Abernathy Robert E was the Director of Haemonetics Corp. (stock ticker symbol HAE).
Also see all insider trading activities at Haemonetics Corp.
Note that in the past
ABERNATHY ROBERT E also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Avient Corp (POL) by Abernathy Robert E
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | POL | 10,000 | $306,420 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Radioshack Corp (RSH) by Abernathy Robert E
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | RSH | 100,000 | $255,029 | 0 | $0 | 0 | $0 |
2012 | RSH | 100,000 | $252,999 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Haemonetics Corp (HAE) by Abernathy Robert E
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | HAE | 4,000 | $323,720 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Kimberly Clark Corp (KMB) by Abernathy Robert E
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2014 | KMB | 0 | $0 | 9,221 | $1,014,310 | 0 | $0 |
2013 | KMB | 0 | $0 | 39,493 | $4,185,878 | 9,393 | $0 |
2012 | KMB | 0 | $0 | 351,006 | $27,442,073 | 217,703 | $12,857,545 |
2011 | KMB | 0 | $0 | 188,934 | $12,291,605 | 199,756 | $10,183,037 |
2010 | KMB | 0 | $0 | 0 | $0 | 9,803 | $0 |
2009 | KMB | 0 | $0 | 96,184 | $5,986,600 | 81,688 | $3,701,211 |
2008 | KMB | 0 | $0 | 0 | $0 | 6,257 | $0 |
2007 | KMB | 0 | $0 | 76,024 | $5,283,158 | 92,588 | $4,777,577 |
2006 | KMB | 0 | $0 | 19,950 | $1,155,723 | 24,406 | $958,496 |
Yearly summary of insider trading at Avanos Medical, Inc. (HYH) by Abernathy Robert E
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | HYH | 10,000 | $310,600 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Abernathy Robert E:
1. Avient Corp (POL)
2. Radioshack Corp (RSH)
3. Haemonetics Corp (HAE)
4. Kimberly Clark Corp (KMB)
5. Avanos Medical, Inc. (HYH)
Table 1. Insider trading of Avient Corp (POL) by Abernathy Robert E
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-10-25 | POL | Buy | 10,000 | 30.64 | 306,420 |
Table 2. Insider trading of Radioshack Corp (RSH) by Abernathy Robert E
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-08-05 | RSH | Buy | 97,000 | 2.55 | 247,349 |
2013-08-02 | RSH | Buy | 3,000 | 2.56 | 7,680 |
2012-07-27 | RSH | Buy | 100,000 | 2.53 | 252,999 |
Table 3. Insider trading of Haemonetics Corp (HAE) by Abernathy Robert E
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-08-11 | HAE | Buy | 4,000 | 80.93 | 323,720 |
Table 4. Insider trading of Kimberly Clark Corp (KMB) by Abernathy Robert E
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2014-02-28 | KMB | Sale | 9,221 | 110.00 | 1,014,310 |
2013-11-27 | KMB | Sale | 13,098 | 108.00 | 1,414,584 |
2013-05-03 | KMB | Sale | 26,282 | 105.00 | 2,759,610 |
2013-04-24 | KMB | Sale | 113 | 103.40 | 11,684 |
2013-02-22 | KMB | Option Ex | 9,393 | .00 | 0 |
2012-11-16 | KMB | Sale | 91,239 | 85.00 | 7,755,315 |
2012-11-16 | KMB | Option Ex | 91,239 | 65.90 | 6,012,923 |
2012-07-30 | KMB | Sale | 25,533 | 87.50 | 2,234,137 |
2012-07-30 | KMB | Option Ex | 25,533 | 49.61 | 1,266,692 |
2012-04-25 | KMB | Option Ex | 2,728 | .00 | 0 |
2012-04-23 | KMB | Sale | 122,470 | 76.50 | 9,368,955 |
2012-04-23 | KMB | Option Ex | 98,203 | 56.80 | 5,577,930 |
2012-02-29 | KMB | Sale | 111,764 | 72.33 | 8,083,666 |
2011-04-26 | KMB | Option Ex | 3,604 | .00 | 0 |
2011-04-25 | KMB | Option Ex | 2,937 | .00 | 0 |
2011-02-10 | KMB | Option Ex | 19,497 | 59.98 | 1,169,332 |
2011-02-11 | KMB | Option Ex | 173,718 | 51.89 | 9,013,705 |
2011-02-10 | KMB | Sale | 18,687 | 65.00 | 1,214,655 |
2011-02-11 | KMB | Sale | 170,247 | 65.06 | 11,076,950 |
2010-04-28 | KMB | Option Ex | 3,082 | .00 | 0 |
2010-04-25 | KMB | Option Ex | 2,937 | .00 | 0 |
2010-04-26 | KMB | Option Ex | 3,784 | .00 | 0 |
2009-11-30 | KMB | Option Ex | 464 | .00 | 0 |
2009-11-04 | KMB | Sale | 20,200 | 62.51 | 1,262,702 |
2009-11-03 | KMB | Sale | 4,800 | 62.50 | 300,000 |
2009-11-02 | KMB | Sale | 45,900 | 62.01 | 2,846,029 |
2009-11-02 | KMB | Option Ex | 45,900 | 51.99 | 2,386,570 |
2009-10-30 | KMB | Sale | 9,100 | 62.02 | 564,363 |
2009-10-30 | KMB | Option Ex | 9,100 | 51.99 | 473,154 |
2009-10-23 | KMB | Sale | 16,184 | 62.62 | 1,013,506 |
2009-10-23 | KMB | Option Ex | 16,184 | 51.99 | 841,487 |
2009-04-28 | KMB | Option Ex | 6,257 | .00 | 0 |
2009-04-26 | KMB | Option Ex | 3,783 | .00 | 0 |
2008-04-28 | KMB | Option Ex | 6,257 | .00 | 0 |
2007-04-28 | KMB | Option Ex | 3,100 | .00 | 0 |
2007-02-01 | KMB | Sale | 39,017 | 69.44 | 2,709,145 |
2007-02-01 | KMB | Option Ex | 44,271 | 55.01 | 2,435,170 |
2007-02-01 | KMB | Option Ex | 4,387 | 49.17 | 215,695 |
2007-01-31 | KMB | Option Ex | 40,830 | 52.09 | 2,126,712 |
2007-02-01 | KMB | Sale | 3,675 | 69.44 | 255,173 |
2007-01-31 | KMB | Sale | 33,332 | 69.57 | 2,318,840 |
2006-02-02 | KMB | Option Ex | 24,406 | 39.27 | 958,496 |
2006-02-02 | KMB | Sale | 19,950 | 57.93 | 1,155,723 |
Table 5. Insider trading of Avanos Medical, Inc. (HYH) by Abernathy Robert E
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-09-04 | HYH | Buy | 10,000 | 31.06 | 310,600 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Abernathy Robert E
(Director of Haemonetics Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.